	The walking experience of persons with multiple sclerosis: a systematic review with evaluation of the sensitivity of the ICF framework to the lived experience. Disabil Rehabil Wood EJ, Galna B, Mavropalias G, Rajakaruna PM, Learmonth YC. PMID: 41530978 [PubMed - as supplied by publisher]
	A real-world study on persistence with ofatumumab in Canadian patients with multiple sclerosis. Mult Scler Relat Disord Selchen D, Grant R, Magnussen C, Murray J, Neish CS. PMID: 41529661 [PubMed - as supplied by publisher]
	Menopause and multiple sclerosis: A scoping review of symptoms, disease course, and lived experience. Maturitas Morgan D, Flores VA, Buxhoeveden S, Motl R, Brounsuzian N, Simpson AC, Hill J, Hardy Y, Román CAF. PMID: 41529424 [PubMed - as supplied by publisher]
	Neurotrauma and multiple sclerosis: the silent catalyst - a systematic review and meta-analysis. Neurol Sci AlHabil Y, Hossoon O, AlQam M, Saife S, Qurt S, Mutawe N, Shamali O, Oweidat M, Yacoub H, Saleh K, Sholi S, Hameedi S, Helal L, Jader A, Abuhassan A. PMID: 41528522 [PubMed - in process]
	Violence and multiple sclerosis: Towards an evidence-informed call to action in neurology. Mult Scler Nesbitt C, Van Der Walt A, Butzkueven H, Rath L, Timmins K, Crosby J, Jokubaitis VG. PMID: 41527696 [PubMed - as supplied by publisher]
	Disease-modifying therapy in pediatric multiple sclerosis. Handb Clin Neurol Wilson E, Chitnis T. PMID: 41526137 [PubMed - indexed for MEDLINE]
	Immunotherapies in progressive multiple sclerosis. Handb Clin Neurol Neziraj T, Kappos L, Pröbstel AK. PMID: 41526136 [PubMed - indexed for MEDLINE]
	Hematopoietic stem cell transplantation for multiple sclerosis: Improving understanding and addressing misconceptions. Handb Clin Neurol Burt RK, Alexander T. PMID: 41526135 [PubMed - indexed for MEDLINE]
	Evolving targeted biologics against T cells, cytokines, and intracellular immune targets for multiple sclerosis with implications in other autoimmune neurologic diseases. Handb Clin Neurol Hemmer B. PMID: 41526132 [PubMed - indexed for MEDLINE]
	Severe autoimmune hepatitis and necrotising pancreatitis following ofatumumab in a patient with multiple sclerosis. BMJ Case Rep Dahshan A, Abouelkhir OE, Badawy ME, Farooq MD, Emara MH, Atta MAAEA, Soliman RME. PMID: 41526077 [PubMed - indexed for MEDLINE]
	Investigating the Effects of Repeated Transcutaneous Spinal Cord Stimulation on Spasticity and Gait in Multiple Sclerosis: A Case Series. IEEE Trans Neural Syst Rehabil Eng Spieker EL, Otto C, Ruprecht K, Schauer T, Salchow-Hommen C, Wenger N. PMID: 41525562 [PubMed - as supplied by publisher]
	A review of multiple sclerosis: From pathophysiology to latest therapeutic advances. AIMS Neurosci Arachchige ASPM, El Choueiri J, Pellicanò F, Laurelli F, Alves GAM, Stomeo N. PMID: 41523333 [PubMed]
	Remyelination as a therapeutic target in the treatment of multiple sclerosis. AIMS Neurosci Garcha GK, Ahmed M. PMID: 41523329 [PubMed]
	Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study. Ther Adv Chronic Dis Al Worikat N, Zanotto A, Lynch SG, Thuringer AJ, Sosnoff JJ, Zanotto T. PMID: 41522449 [PubMed]
	Progressive multiple sclerosis: Six trials to watch. Med Rocca MA, Preziosa P, Filippi M. PMID: 41519116 [PubMed - indexed for MEDLINE]
	Real-world COVID-19 immunity in multiple sclerosis (CoVaR-MS): A longitudinal follow up study. Mult Scler Relat Disord Kalra S, Jenkinson D, Goddard S, Banavathi K, Salim O, Abraham RJ, Jordan KP. PMID: 41518821 [PubMed - as supplied by publisher]
	Letter to the editor on "efficacy of caffeine supplementation on fatigue in patients with multiple sclerosis: A randomized double-blind placebo-controlled trial". Mult Scler Relat Disord Pakkhesal S, Sanaie S, Naseri A. PMID: 41518816 [PubMed - as supplied by publisher]
	Efficacy and safety of Bruton's tyrosine kinase inhibitors compared to Teriflunomide in relapsing multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord Sobral MVS, de Oliveira HM, Neto APM, Fagundes TP. PMID: 41518815 [PubMed - as supplied by publisher]
	The burden of multiple sclerosis in Japan from 1990 to 2021 and predictions to 2050 based on the Global Burden of Disease study 2021. Neuroepidemiology Wang R, Cossu D, Tomizawa Y, Hattori N, Hatano T. PMID: 41518640 [PubMed - as supplied by publisher]
	Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments. J Neurol Greco G, Della Porta G, Masi F, Redemagni C, Ahmad L, Caverzasi E, Bergamaschi R, Terzaghi M, Gastaldi M, Rigoni E, Pichiecchio A, Colombo E, Tavazzi E. PMID: 41518393 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 43103

Page 1 of 2156



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy